Cargando…
Outcomes and Timing of Bedside Percutaneous Tracheostomy of COVID-19 Patients over a Year in the Intensive Care Unit
Background: The benefits and timing of percutaneous dilatational tracheostomy (PDT) in Intensive Care Unit (ICU) COVID-19 patients are still controversial. PDT is considered a high-risk procedure for the transmission of SARS-CoV-2 to healthcare workers (HCWs). The present study analyzed the optimal...
Autores principales: | Tetaj, Nardi, Maritti, Micaela, Stazi, Giulia, Marini, Maria Cristina, Centanni, Daniele, Garotto, Gabriele, Caravella, Ilaria, Dantimi, Cristina, Fusetti, Matteo, Santagata, Carmen, Macchione, Manuela, De Angelis, Giada, Giansante, Filippo, Busso, Donatella, Di Lorenzo, Rachele, Scarcia, Silvana, Carucci, Alessandro, Cabas, Ricardo, Gaviano, Ilaria, Petrosillo, Nicola, Antinori, Andrea, Palmieri, Fabrizio, D’Offizi, Gianpiero, Ianniello, Stefania, Campioni, Paolo, Pugliese, Francesco, Vaia, Francesco, Nicastri, Emanuele, Ippolito, Giuseppe, Marchioni, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347124/ https://www.ncbi.nlm.nih.gov/pubmed/34362118 http://dx.doi.org/10.3390/jcm10153335 |
Ejemplares similares
-
Epidemiology, Clinical Presentation and Treatment of Non-Hepatic Hyperammonemia in ICU COVID-19 Patients
por: Tetaj, Nardi, et al.
Publicado: (2022) -
Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital
por: Tetaj, Nardi, et al.
Publicado: (2021) -
Epidemiology of ventilator-associated pneumonia in ICU COVID-19 patients: an alarming high rate of multidrug-resistant bacteria
por: Tetaj, Nardi, et al.
Publicado: (2022) -
Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital
por: Tetaj, Nardi, et al.
Publicado: (2022) -
National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management
por: Nicastri, Emanuele, et al.
Publicado: (2020)